Admetsys: An artificial pancreas for hospital settings
Boston-based startup Admetsys has developed what it calls a first-of-its kind artificial pancreas specifically designed for hospital and surgical settings. The company said the device will eliminate the need for nurses to hand check glucose levels for patients at diabetic risk during their hospital stays, and could free up as much as 20% of a nurses time on shift.
Though still in its early stages, the company has conducted 3 clinical trials of the device and has racked up victories at various global innovation contests including a competition sponsored by the Massachusetts Medical Device Development Center out of its University of Massachusetts Lowell campus.
The company’s artificial pancreas system is specifically designed to improve hospital care for patients at diabetic risk by controlling blood glucose and protecting the patient from hypoglycemia by infusing counterbalancing insulin and dextrose medications. The system monitors blood glucose levels in real time, the company said, and creates a computational model of the patient’s metabolism to deliver a personally optimized treatment.
Last January, Admetsys inked a collaborative deal with Hospira to use its 50% dextrose for injection and its Ansyr II polypropylene syringe system as part of its artificial pancreas platform.
Gayle Kirma says
I’m patiently waiting for this to hit the marke; T1 for 58 years!
Thank you!
Chris Newmarker says
Thanks for the comment, Gayle. Hope you don’t have to wait much longer!
James Dunlop says
but what about the advancements in this? worth looking at, it is being investigated by the same people that are investing in this product. hope for us T1 diabetics is coming, one way or another. there is hope.
http://thejdca.org/practical-cure-project-update-bcg
Erika Payne says
Hats off to you, Gayle.
Waiting impatiently.
Mum of a 10-year-old T1
Debbie says
How do i get to be in the trial?
Ronnie McBride says
This will be great. I am 67 years old and am fighting the battle of diabetes. I would love to trial test something like this. I worked in the Medical field for 39 years and was always studying how to beat this terrible disease.
Ronnie McBride
James Culp says
I wish all success. I hope for biological approach to protect islet insulin producing cells for implant or infusion of cells to restore natural function of glucose metabolism. May God help us.
Pat McAlister says
T1D for 70 years. Why not a cure instead of costing us more and more to live. We are the support of these drug and device companies. Thank you for this article. I do a diabetic newsletter for a T1D optimist club. Our next speaker is building his own device.
Chris Newmarker says
Thanks for the insights, Pat. I think it really says something about the motivation of the diabetes community that there’s so much do-it-yourself activity going on with devices, including when it comes to an artificial pancreas. Who do you have speaking?
Frank van Olffen says
You forgetting a big player in the Netherlands.
https://inredadiabetic.nl
Chris Newmarker says
Thanks for pointing out, Frank!